187 related articles for article (PubMed ID: 15880468)
1. Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.
Logigian EL; Blood CL; Dilek N; Martens WB; Moxley RT; Wiegner AW; Thornton CA; Moxley RT
Muscle Nerve; 2005 Jul; 32(1):35-42. PubMed ID: 15880468
[TBL] [Abstract][Full Text] [Related]
2. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).
Moxley RT; Logigian EL; Martens WB; Annis CL; Pandya S; Moxley RT; Barbieri CA; Dilek N; Wiegner AW; Thornton CA
Muscle Nerve; 2007 Sep; 36(3):320-8. PubMed ID: 17587223
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.
Logigian EL; Moxley RT; Blood CL; Barbieri CA; Martens WB; Wiegner AW; Thornton CA; Moxley RT
Neurology; 2004 Apr; 62(7):1081-9. PubMed ID: 15079005
[TBL] [Abstract][Full Text] [Related]
4. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
5. Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1.
Logigian EL; Twydell P; Dilek N; Martens WB; Quinn C; Wiegner AW; Heatwole CR; Thornton CA; Moxley RT
Muscle Nerve; 2010 Feb; 41(2):191-6. PubMed ID: 19750543
[TBL] [Abstract][Full Text] [Related]
6. Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.
Horáková M; Horák T; Parmová O; Bednařík J; Voháňka S
Muscle Nerve; 2019 Apr; 59(4):431-435. PubMed ID: 30575988
[TBL] [Abstract][Full Text] [Related]
7. Quantitative myotonia assessment using force relaxation curve modelling.
Hogrel JY
Physiol Meas; 2009 Jul; 30(7):719-27. PubMed ID: 19549998
[TBL] [Abstract][Full Text] [Related]
8. Cortical involvement during myotonia in myotonic dystrophy: an fMRI study.
Toth A; Lovadi E; Komoly S; Schwarcz A; Orsi G; Perlaki G; Bogner P; Sebok A; Kovacs N; Pal E; Janszky J
Acta Neurol Scand; 2015 Jul; 132(1):65-72. PubMed ID: 25630356
[TBL] [Abstract][Full Text] [Related]
9. Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
Aldehag A; Jonsson H; Lindblad J; Kottorp A; Ansved T; Kierkegaard M
Disabil Rehabil; 2013 Oct; 35(21):1798-807. PubMed ID: 23480644
[TBL] [Abstract][Full Text] [Related]
10. Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophy.
Bulea TC; Guth A; Sarkar N; Gravunder A; Hodsdon B; Farrell K; Comis LE; Parks R; Shimellis H; Ndege V; Ho PS; Mankodi A
Neuromuscul Disord; 2022 Apr; 32(4):321-331. PubMed ID: 35305880
[TBL] [Abstract][Full Text] [Related]
11. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.
Torres C; Moxley RT; Griggs RC
J Neurol Sci; 1983 Jul; 60(1):157-68. PubMed ID: 6875612
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy: quantification of muscle weakness and myotonia and the effect of amitriptyline and exercise.
Milner-Brown HS; Miller RG
Arch Phys Med Rehabil; 1990 Nov; 71(12):983-7. PubMed ID: 2241546
[TBL] [Abstract][Full Text] [Related]
13. Grip and percussion myotonia in myotonic dystrophy type 1.
Hughes BN; Hogue JS; Hsieh DT
J Pediatr; 2014 May; 164(5):1234-1234.e1. PubMed ID: 24560185
[No Abstract] [Full Text] [Related]
14. Improved grip myotonia in a patient with myotonic dystrophy type 1 following electroacupuncture therapy: A CARE-compliant case report.
Yoon SH; Baek JH; Leem J
Medicine (Baltimore); 2020 Sep; 99(37):e21845. PubMed ID: 32925721
[TBL] [Abstract][Full Text] [Related]
15. Transient paresis in myotonic syndromes. A surface EMG study.
Zwarts MJ; van Weerden TW
Brain; 1989 Jun; 112 ( Pt 3)():665-80. PubMed ID: 2731026
[TBL] [Abstract][Full Text] [Related]
16. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular excitability properties in myotonic dystrophy type 1.
Boërio D; Hogrel JY; Bassez G; Lefaucheur JP
Clin Neurophysiol; 2007 Nov; 118(11):2375-82. PubMed ID: 17890147
[TBL] [Abstract][Full Text] [Related]
18. Development of a disability scale for myotonic dystrophy type 1.
Contardi S; Pizza F; Falzone F; D'Alessandro R; Avoni P; Di Stasi V; Montagna P; Liguori R
Acta Neurol Scand; 2012 Jun; 125(6):431-8. PubMed ID: 21902674
[TBL] [Abstract][Full Text] [Related]
19. Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1.
Esposito F; Cè E; Rampichini S; Limonta E; Venturelli M; Monti E; Bet L; Fossati B; Meola G
Neuromuscul Disord; 2016 Jan; 26(1):60-72. PubMed ID: 26520850
[TBL] [Abstract][Full Text] [Related]
20. [Muscular disability and organ impairments in myotonic dystrophy type 1].
Pruna L; Machado F; Louis L; Vassé G; Kaminsky P
Rev Neurol (Paris); 2011 Jan; 167(1):23-8. PubMed ID: 20934732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
